Vyne Therapeutics Inc. · NASDAQ:VYNE

Domzalski David received 30,791 Vyne Therapeutics Inc. shares as an award (Form 4)

Traded May 29, 2026 · Filed Jun 2, 2026

On May 29, 2026, Domzalski David (Director, PRESIDENT AND CEO) received 30,791 Vyne Therapeutics Inc. shares as an award at US$0.31 for US$9,545, leaving 438,779 shares. Filed Jun 2, 2026 (Form 4).

Awarded: 30,791 shares
Price: US$0.31
Value: US$9,545
Holding after: 438,779 shares
Trading plan: No
Role: Director, PRESIDENT AND CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
May 29, 2026	Common Stock	Award	30,791	US$0.31	438,779	Direct

Source

View original at SEC

Related